Blog
Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
Update from Baloise on its new financial reporting under IFRS 17/9
Update from Baloise on its new financial reporting under IFRS 17/9
Acquisition of leading Value Add Distributor Commaxx: ALSO further expands expertise in Cloud
Acquisition of leading Value Add Distributor Commaxx: ALSO further expands expertise in Cloud
EQS-News: HAMBORNER REIT AG publishes Sustainability Report 2022
EQS-News: HAMBORNER REIT AG publishes Sustainability Report 2022
EQS-Adhoc: GN Store Nord A/S: GN announces divestment of BelAudição
EQS-Adhoc: GN Store Nord A/S: GN announces divestment of BelAudição
EQS-News: LION E-Mobility AG: General Meeting of Shareholders discharges Board and approves annual financial statements, and Board as well as Management for another year
EQS-News: LION E-Mobility AG: General Meeting of Shareholders discharges Board and approves annual financial statements, and Board as well as Management for another year
EQS-News: Cannovum Cannabis AG :Cannovum Cannabis AG: Planned capital measures with reverse stock split and change in the supervisory board
EQS-News: Cannovum Cannabis AG :Cannovum Cannabis AG: Planned capital measures with reverse stock split and change in the supervisory board
EQS-News: Strong performance: Your Family Entertainment AG presents excellent annual results at its annual shareholder meeting and looks to the future with confidence
EQS-News: Strong performance: Your Family Entertainment AG presents excellent annual results at its annual shareholder meeting and looks to the future with confidence
EQS-News: CPI PROPERTY GROUP – Green Bond Issue by S IMMO
EQS-News: CPI PROPERTY GROUP – Green Bond Issue by S IMMO
EQS-News: Defence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS
EQS-News: Defence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS
MBH Corporation Plc: Result of AGM and Appointment of New Directors
MBH Corporation Plc: Result of AGM and Appointment of New Directors
EQS-News: audius SE: Successful Presence AGM votes to increase dividend to 35 cents per share
EQS-News: audius SE: Successful Presence AGM votes to increase dividend to 35 cents per share
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Best of the Best PLC
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Best of the Best PLC
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Sureserve PLC
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Sureserve PLC
EQS-Adhoc: RAVENO Capital AG: New appointment of sole member of the Management Board
EQS-Adhoc: RAVENO Capital AG: New appointment of sole member of the Management Board
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
EQS-News: Anonymous Intelligence Company Announces Beta Launch Date of Turminal.ai, Mobile Alpha, New Website and over 38,000 Signups To Waitlist.
EQS-News: Anonymous Intelligence Company Announces Beta Launch Date of Turminal.ai, Mobile Alpha, New Website and over 38,000 Signups To Waitlist.
EQS-News: Dr. Harald Schrimpf resigns from the Executive Board
EQS-News: Dr. Harald Schrimpf resigns from the Executive Board
EQS-News: Nabaltec AG: Shareholders adopt dividend in the amount of EUR 0.28 per share
EQS-News: Nabaltec AG: Shareholders adopt dividend in the amount of EUR 0.28 per share
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
EQS-News: Affluent Medical Presents Poster on First Successful Procedure with Epygon at the 2023 CSI Conference in Frankfurt
EQS-News: Affluent Medical Presents Poster on First Successful Procedure with Epygon at the 2023 CSI Conference in Frankfurt
EQS-News: BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
EQS-News: BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
EQS-News: Samara’s Proposed Dividend of EUR 1.30 per Share is proposed to have a Record Date of July 4, 2023, same as the EGM Date
EQS-News: Samara’s Proposed Dividend of EUR 1.30 per Share is proposed to have a Record Date of July 4, 2023, same as the EGM Date


